Tag Archives: Heart

ADA: Novo Nordisk’s oral semaglutide posts another heart safety win

SAN FRANCISCO—Novo Nordisk may have already submitted its approval application for its oral GLP-1 drug semaglutide, but the deluge of positive data hasn’t stopped. Tuesday at the American Diabetes Association annual meeting, the Danish drugmaker rolled out cardiovascular outcomes results showing that the its wannabe blockbuster didn’t hurt cardiovascular safety in high-risk Type 2 diabetes… Read More »

The heart and science of kindness

Kindness (noun): the quality of being friendly, generous, and considerate; a kind act.— English Oxford Living Dictionaries Ombudspeople like myself have a unique view of the institutions they serve. Some of us fondly refer to it as the “view from the underbelly” of our organizations. The urgent calls we get aren’t to share a recent… Read More »